3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
6
Keratosis, Actinic
5
Brain Neoplasms
5
Glioma
4
Skin Diseases
2
Precancerous Conditions
2
Neoplasms
2
Carcinoma, Basal Cell
2
Squamous Cell Carcinoma of Head and Neck
1
Skull Base Neoplasms
1
Sarcoma
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Non-Melanoma Skin Cancer (NMSC)
1
Mouth Neoplasms
1
Meningioma
1
Lichen Planus, Oral
1
Leukoplakia, Oral
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Colorectal Neoplasms
1
Carcinoma in Situ
1
Breast Neoplasms
1
Astrocytoma
1
Interventions
Cyclophosphamide
61
Rituximab
50
fludarabine
34
Prednisone
33
Doxorubicin
28
Biopsy
26
Vincristine
25
Specimen Handling
22
Magnetic Resonance Spectroscopy
20
Bendamustine Hydrochloride
19
pembrolizumab
16
Lenalidomide
16
obinutuzumab
14
fludarabine phosphate
14
Etoposide
14
venetoclax
13
Tacrolimus
11
Mycophenolic Acid
10
Melphalan
10
Dexamethasone
10
zanubrutinib
9
ibrutinib
9
acalabrutinib
9
Radiotherapy
9
Gemcitabine
9
Cytarabine
9
Busulfan
9
Whole-Body Irradiation
8
Mesna
8
Filgrastim
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma
×
Aminolevulinic Acid
×
1 year
×
Clear all
No trials found.